Jane Street’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-154,000
Closed -$4.15M 10451
2022
Q4
$4.15M Buy
154,000
+85,100
+124% +$2.24M ﹤0.01% 2745
2022
Q3
$1.24M Buy
68,900
+25,800
+60% +$412K ﹤0.01% 5035
2022
Q2
$536K Buy
43,100
+14,800
+52% +$163K ﹤0.01% 6611
2022
Q1
$377K Buy
+28,300
New +$379K ﹤0.01% 7996
2021
Q4
Sell
-21,700
Closed -$487K 11065
2021
Q3
$487K Sell
21,700
-16,500
-43% -$362K ﹤0.01% 7329
2021
Q2
$870K Buy
38,200
+6,700
+21% +$141K ﹤0.01% 6126
2021
Q1
$648K Sell
31,500
-100,600
-76% -$2.29M ﹤0.01% 6321
2020
Q4
$3.65M Buy
132,100
+82,200
+165% +$1.6M ﹤0.01% 2536
2020
Q3
$701K Sell
49,900
-33,100
-40% -$616K ﹤0.01% 4654
2020
Q2
$1.71M Buy
+83,000
New +$1.13M ﹤0.01% 3279

Other funds holding MYOV

Jane Street's MYOV Position: Q1 2023 in Review

Jane Street sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 18,064 shares — an estimated $487K sold.

Jane Street first reported a position in MYOV in Q4 2019 and held it in 11 quarters. The position peaked at $1.53M in Q2 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Jane Street reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 18,064 Myovant Sciences Ltd. shares in Q1 2023, an estimated $487K.
  • Jane Street first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 11 quarters.
  • Jane Street's Myovant Sciences Ltd. position peaked at $1.53M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.